Sources | Names Used |
---|---|
CCLE, FIMM | Irinotecan |
gCSI | irinotecan |
GRAY | CPT-11 |
PharmacoGx | Irinotecan |
Database | Identifier |
---|---|
Smiles: | CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7 |
Inchikey: | UWKQSNNFCGGAFS-XIFFEERXSA-N |
Pubchem: | 60838 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLFN11 | CCLE | pan-cancer | AAC | 0.41 | 1e-14 |
mRNA | CPSF6 | CCLE | pan-cancer | AAC | 0.42 | 4e-10 |
mRNA | CD63 | CCLE | pan-cancer | AAC | -0.39 | 2e-09 |
mRNA | RFXAP | CCLE | pan-cancer | AAC | 0.37 | 4e-09 |
mRNA | TAF5 | CCLE | pan-cancer | AAC | 0.34 | 4e-09 |
mRNA | HNRNPC | CCLE | pan-cancer | AAC | 0.32 | 7e-09 |
mRNA | PTPRM | CCLE | pan-cancer | AAC | -0.34 | 1e-08 |
mRNA | TMPO | CCLE | pan-cancer | AAC | 0.32 | 1e-08 |
mRNA | NSL1 | CCLE | pan-cancer | AAC | 0.33 | 1e-08 |
mRNA | FBXO5 | CCLE | pan-cancer | AAC | 0.32 | 2e-08 |